Disease | mycosis fungoides |
Phenotype | C1276146|cutaneous lymphoma |
Sentences | 2 |
PubMedID- 22924950 | Efficacy and safety of bexarotene combined with psoralen-ultraviolet a (puva) compared with puva treatment alone in stage ib-iia mycosis fungoides: final results from the eortc cutaneous lymphoma task force phase iii randomized clinical trial (nct00056056). |
PubMedID- 24889480 | T-cell lymphomas represent at least two thirds of all primary cutaneous lymphomas with mycosis fungoides and sezary syndrome being the most frequent entities. |
Page: 1